How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’

CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate may be better than psilocybin.

How Mindset Pharma Is Making and Defining 'Next-Generation Psychedelic Drugs'